Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-017635
Filing Date
2018-12-20
Accepted
2018-12-20 16:55:17
Documents
1
Period of Report
2018-12-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3940
  Complete submission text file 0001213900-18-017635.txt   5366
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 WEST 18TH STREET, APT 4B NEW YORK NY 10011
Business Address
Shenouda Maged (Reporting) CIK: 0001658369 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55347 | Film No.: 181246768